Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial

IMPORTANCE: Studies in experimental and human heart failure suggest that phosphodiesterase type-5 inhibitors may enhance cardiovascular function, and thus, exercise capacity in heart failure with preserved ejection fraction. OBJECTIVE: To determine the effect of the phosphodiesterase type-5 inhibito...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Redfield, Margaret M, Chen, Horng H, Borlaug, Barry A, Semigran, Marc J., Lee, Kerry L., Lewis, Gregory, LeWinter, Martin M., Rouleau, Jean L., Bull, David A., Mann, Douglas L., Deswal, Anita, Stevenson, Lynne W., Givertz, Michael M., Ofili, Elizabeth O., O’Connor, Christopher M., Felker, G. Michael, Goldsmith, Steven R., Bart, Bradley A., McNulty, Steven E, Ibarra, Jenny C., Lin, Grace, Oh, Jae K., Patel, Manesh R., Kim, Raymond J., Tracy, Russell P., Velazquez, Eric J., Anstrom, Kevin J., Hernandez, Adrian F., Mascette, Alice M., Braunwald, Eugene
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3835156/
https://ncbi.nlm.nih.gov/pubmed/23478662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2013.2024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados